CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- 4 Grant or award CHIEF TECHNICAL OPS OFFICER acquired 18,020 shares (grant or award)
- 4 Grant or award SVP, CHIEF ACCOUNTING OFFICER acquired 13,250 shares (grant or award)
- 4 Grant or award EVP & CHIEF MEDICAL OFFICER acquired 18,750 shares (grant or award)
- 4 Grant or award CHIEF BUSINESS OFFICER acquired 20,000 shares (grant or award)
- 4 Planned sale EXEC. VP AND CLO sold 2,266 shares at an average $75.55 ($171,192)
- 4 Planned sale Director sold 734 shares at $76.00 ($55,784)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 20,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 63,000 shares (grant or award)
- 4 Planned sale Director sold 12,000 shares at $76.35 ($916,200)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 8,089 shares at $76.64 ($619,941)
- 4 Planned sale CHIEF BUSINESS OFFICER sold 20,508 shares at an average $77.26 ($1,584,350)
- 4 Planned sale CHIEF BUSINESS OFFICER sold 43,492 shares at an average $75.40 ($3,279,275)
- 4 Exercise or conversion Director acquired 24,000 shares (option exercise)
- 4 Planned sale Director sold 733 shares at $78.62 ($57,628)
Page 4 of 31 · 617 filings